Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00102245 · ClinicalTrials.gov registry record

Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Terminated
Registry status
334
Enrollment target

NCT00102245 is a clinical trial that was terminated before completion, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 334 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00102245 was terminated before completion, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

TERMINATED
Registry status
334 participants
Enrollment target

Study Summary

This study will examine blood for factors that may cause or prevent diseases involving iron or red blood cells. Iron is an important nutrient for human health that is needed to produce red blood cells. Red blood cells carry oxygen to body tissues. A better understanding of iron and red blood cells may help lead to better treatment of several diseases including anemia. Patients of all ages with red cell abnormalities in the following categories may be eligible for this study: * Diseases with deficiency, overload or maldistribution of iron * Known red blood cell diseases, such as anemias and hemoglobinopathies * Red blood cell diseases of unknown cause, such as hemolysis of unknown cause * Red blood cell abnormalities with no overt clinical disease, such as hereditary persistence of fetal hemoglobin Participants undergo the following procedures: * Medical history * Physical examination * Standard medical tests related to the individual's iron or red blood cell condition Blood draw for the following purposes: * Testing for syphilis and for the hepatitis B and C, HIV, and HTLV-1viruses, and for a pregnancy test for women who can become pregnant * Research purposes. This blood is analyzed for genes, proteins, sugars, and fat molecules.

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2005-01-18
Est. Completion 2017-08-04

What the Registry Record Tells You About NCT00102245

The ClinicalTrials.gov registry entry for NCT00102245 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00102245 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00102245 about?

NCT00102245 is a clinical study titled "Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes". This study will examine blood for factors that may cause or prevent diseases involving iron or red blood cells. Iron is an important nutrient for human health that is needed to produce red blood cells. Red blood cells carry oxygen to body tissues. A better understanding of iron and red blood cells m...

What is the current status of trial NCT00102245?

This trial is currently terminated. The enrollment target is 334 participants. The study started on 2005-01-18. Estimated completion is 2017-08-04.

Who is sponsoring clinical trial NCT00102245?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.